MindWalk Holdings (HYFT) Current Deferred Revenue (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Current Deferred Revenue came in at $782760.0 in Q2 2026, up 2.19% year-over-year from $765974.3 in Q2 2025, and up 15.44% quarter-over-quarter from $678056.1 in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Current Deferred Revenue (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Current Deferred Revenue for 7 consecutive years, with $782760.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Deferred Revenue rose 2.19% year-over-year to $782760.0 in Q2 2026; TTM through Apr 2026 was $782760.0, a 2.19% increase from a year earlier, with the FY2026 full-year figure at $777614.3, down 0.62% from the prior year.
- Current Deferred Revenue was $782760.0 for Q2 2026 at MindWalk Holdings, up from $678056.1 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.7 million in Q1 2025 and troughed at $565489.2 in Q3 2025.
- A 5-year average of $929064.6 and a median of $830376.3 in 2022 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue soared 148.27% in 2024 and slumped 59.09% in 2026, its largest moves.
- Over 5 years, Current Deferred Revenue stood at $885405.0 in 2022, then soared by 34.19% to $1.2 million in 2023, then grew by 5.83% to $1.3 million in 2024, then sank by 47.65% to $658162.5 in 2025, then increased by 18.93% to $782760.0 in 2026.
- The last three Current Deferred Revenue figures came in at $782760.0 (Q2 2026), $678056.1 (Q1 2026), and $658162.5 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 782,759.96 |
| Jan 31, 2026 | 678,056.09 |
| Oct 31, 2025 | 658,162.53 |
| Jul 31, 2025 | 565,489.20 |
| Apr 30, 2025 | 765,974.27 |
| Jan 31, 2025 | 1.66 Mn |
| Oct 31, 2024 | 1.26 Mn |
| Jul 31, 2024 | 950,135.88 |
| Apr 30, 2024 | 997,127.42 |
| Jan 31, 2024 | 1.50 Mn |
| Oct 31, 2023 | 1.19 Mn |
| Jul 31, 2023 | 844,352.69 |
| Apr 30, 2023 | 722,051.05 |
| Jan 31, 2023 | 602,753.66 |
| Oct 31, 2022 | 885,405.02 |
| Jul 31, 2022 | 1.08 Mn |
| Apr 30, 2022 | 816,400.01 |
| Jan 31, 2022 | 776,650.25 |
| Oct 31, 2021 | 1.03 Mn |
| Jul 31, 2021 | 1.02 Mn |